While NAD precursors and therapies are generally well-tolerated, individuals should consult qualified healthcare professionals before combining them with certain medications, active chemotherapy treatments, or high doses of specific compounds that influence cellular methylation or oxidative pathways. Because clinical research regarding direct intravenous NAD infusions and advanced precursor supplementation continues to evolve, patients must disclose all concurrent medications, vitamins, and underlying health conditions to avoid adverse physiological interactions.